ASN's Mission

ASN leads the fight to prevent, treat, and cure kidney diseases throughout the world by educating health professionals and scientists, advancing research and innovation, communicating new knowledge, and advocating for the highest quality care for patients.

learn more

Contact ASN

1401 H St, NW, Ste 900, Washington, DC 20005


The Latest on Twitter

Coronavirus Disease 2019 (COVID-19)

COVID-19 Information

Support of ASN's COVID-19 activities is provided by:   AstraZeneca Natera Logos

on COVID-19

Hot Topics: Vaccines Monoclonal Antibodies COVID-19 Toolkit Webinars Podcasts

Official CDC Health Alert

Cases of Cerebral Venous Sinus Thrombosis with Thrombocytopenia after Receipt of the Johnson & Johnson COVID-19 Vaccine

As of April 12, 2021, approximately 6.85 million doses of the Johnson & Johnson (J&J) COVID-19 vaccine (Janssen) have been administered in the United States. The Centers for Disease Control and Prevention (CDC) and the U.S. Food and Drug Administration (FDA) are reviewing data involving six U.S. cases of a rare type of blood clot in individuals after receiving the J&J COVID-19 vaccine that were reported to the Vaccine Adverse Event Reporting System (VAERS).

CDC Health Alert FDA/CDC Statement ASH FAQ COCA Call link

COVID-19 ASN Spotlight

USRDS COVID-19 Annual Report Suppliment
Acute Kidney Injury (AKI) Compendium
ASN/HHS COVID-19 Scarce Resources Roundtable and Summary Report
In this supplemental chapter of the Annual Data Report, the USRDS provides the first national description of the impact of coronavirus disease 2019 (COVID-19) on the ESRD population in the United States. With guidance from the AKI!Now Steering Committee, the American Society of Nephrology (ASN) has launched the AKI Compendium, designed to promote excellence in the prevention and treatment of acute kidney injury (AKI). The American Society of Nephrology (ASN) in partnership with the U.S. Department of Health and Human Services (HHS) hosted two 90-minute sessions with clinicians who were practicing in the acute in-hospital nephrology setting and experiencing a surge in COVID-19 outbreaks.

USRDS Supplement

AKI Compendium

Full Report


AKI!Now Homepage

Hot Spot Resources


The CDC has updated the Interim Additional Guidance for Infection Prevention and Control Recommendations for Patients with Suspected or Confirmed COVID-19 in Outpatient Hemodialysis Facilities.

Revisions made on December 16, 2020

  • Added link to FAQ addressing when options to reduce quarantine for contacts of persons with SARS-CoV-2 infection might be considered in healthcare settings.

ASN Resources and Recommendations

The CDC Coronavirus Disease 2019 (COVID-19) Information

Centers for Medicare & Medicaid Services (CMS) COVID-19 Updates

Other Healthcare Organizations


Nephrologists Transforming Dialysis Safety (NTDS)

Press Contact:
Christine Feheley
Media and Communications
ASN Alliance for Kidney Health
Phone: 202-640-4638
Fax: 202-637-9793